The closing of the private placement is expected to occur on or about January 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics. Even cells with the same DNA can act differently because their molecules ...
The Chosun Ilbo on MSN
K-Bio stocks surge 80%: Will momentum continue in 2025?
Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were ...
A team of materials scientists has developed a new bio based carbon material that can store thermal energy more efficiently ...
Leading Futurist Roger Spitz Expands Foresight Offerings Focused on Global Disorder, Grand Strategy & the “Three Gs”: Geopolitics, Geoeconomics & Geotechnology Formalizing this expansion, the ...
How Delaware schoolkids turned the agile gray fox into a symbol of history, resilience, and year‑round wildness.
The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering.Enhance your knowledge in protein ...
BENGALURU: The Common Entrance Test 2026 will be held on April 23 and 24, announced Higher Education Minister Dr MC Sudhakar ...
Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...
A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...
As growers plan for 2026, establishing a weather-resilient nitrogen foundation is becoming a key part of cotton fertility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback